SEQUANS COMMUNICATIONS-ADR (SQNS) Fundamental Analysis & Valuation

NYSE:SQNS • US8173234050

Current stock price

2.54 USD
-0.38 (-13.01%)
At close:
2.62 USD
+0.08 (+3.15%)
After Hours:

This SQNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SQNS Profitability Analysis

1.1 Basic Checks

  • SQNS had negative earnings in the past year.
  • In the past year SQNS has reported a negative cash flow from operations.
  • SQNS had negative earnings in 4 of the past 5 years.
  • In the past 5 years SQNS always reported negative operating cash flow.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

  • SQNS has a worse Return On Assets (-44.24%) than 87.83% of its industry peers.
  • SQNS's Return On Equity of -86.24% is on the low side compared to the rest of the industry. SQNS is outperformed by 86.96% of its industry peers.
Industry RankSector Rank
ROA -44.24%
ROE -86.24%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 -400 600 -600

1.3 Margins

  • SQNS's Gross Margin of 53.96% is fine compared to the rest of the industry. SQNS outperforms 70.43% of its industry peers.
  • SQNS's Gross Margin has improved in the last couple of years.
  • SQNS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.47%
GM growth 5Y3.35%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SQNS Health Analysis

2.1 Basic Checks

  • SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SQNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • SQNS has an Altman-Z score of 1.06. This is a bad value and indicates that SQNS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of SQNS (1.06) is worse than 72.17% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that SQNS is somewhat dependend on debt financing.
  • SQNS has a Debt to Equity ratio of 0.57. This is in the lower half of the industry: SQNS underperforms 72.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACC11.93%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

2.3 Liquidity

  • SQNS has a Current Ratio of 0.89. This is a bad value and indicates that SQNS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.89, SQNS is not doing good in the industry: 92.17% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.79 indicates that SQNS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.79, SQNS is doing worse than 91.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.79
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SQNS Growth Analysis

3.1 Past

  • The earnings per share for SQNS have decreased strongly by -133.61% in the last year.
  • The Revenue for SQNS has decreased by -25.48% in the past year. This is quite bad
  • SQNS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.79% yearly.
EPS 1Y (TTM)-133.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48.75%
Revenue 1Y (TTM)-25.48%
Revenue growth 3Y-23.42%
Revenue growth 5Y-11.79%
Sales Q2Q%-36.6%

3.2 Future

  • Based on estimates for the next years, SQNS will show a very strong growth in Earnings Per Share. The EPS will grow by 37.64% on average per year.
  • The Revenue is expected to grow by 48.34% on average over the next years. This is a very strong growth
EPS Next Y85.11%
EPS Next 2Y37.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year62.85%
Revenue Next 2Y46.86%
Revenue Next 3Y48.34%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. SQNS Valuation Analysis

4.1 Price/Earnings Ratio

  • SQNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SQNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SQNS's earnings are expected to grow with 37.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.64%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SQNS Dividend Analysis

5.1 Amount

  • No dividends for SQNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SQNS Fundamentals: All Metrics, Ratios and Statistics

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (3/27/2026, 8:04:00 PM)

After market: 2.62 +0.08 (+3.15%)

2.54

-0.38 (-13.01%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners61.75%
Inst Owner Change10.46%
Ins Owners12.82%
Ins Owner Change0%
Market Cap364.04M
Revenue(TTM)27.45M
Net Income(TTM)-110.14M
Analysts82
Price Target12.75 (401.97%)
Short Float %3.75%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.43%
Min EPS beat(2)-127.27%
Max EPS beat(2)40.42%
EPS beat(4)2
Avg EPS beat(4)-17.3%
Min EPS beat(4)-127.27%
Max EPS beat(4)40.42%
EPS beat(8)5
Avg EPS beat(8)100.98%
EPS beat(12)7
Avg EPS beat(12)63.77%
EPS beat(16)10
Avg EPS beat(16)64.12%
Revenue beat(2)0
Avg Revenue beat(2)-18.39%
Min Revenue beat(2)-32.9%
Max Revenue beat(2)-3.88%
Revenue beat(4)1
Avg Revenue beat(4)-18.82%
Min Revenue beat(4)-48.17%
Max Revenue beat(4)9.67%
Revenue beat(8)4
Avg Revenue beat(8)4.04%
Revenue beat(12)4
Avg Revenue beat(12)-4.81%
Revenue beat(16)5
Avg Revenue beat(16)-3.97%
PT rev (1m)0%
PT rev (3m)-37.5%
EPS NQ rev (1m)-0.75%
EPS NQ rev (3m)-3.85%
EPS NY rev (1m)-4.4%
EPS NY rev (3m)-4.4%
Revenue NQ rev (1m)-4.21%
Revenue NQ rev (3m)-17.08%
Revenue NY rev (1m)1.81%
Revenue NY rev (3m)-4.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.26
P/FCF N/A
P/OCF N/A
P/B 2.85
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.58
EYN/A
EPS(NY)-1.13
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.19
BVpS0.89
TBVpS-0.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -44.24%
ROE -86.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.47%
GM growth 5Y3.35%
F-Score1
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4819.03%
Cap/Sales 1395.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.79
Altman-Z 1.06
F-Score1
WACC11.93%
ROIC/WACCN/A
Cap/Depr(3y)1777.69%
Cap/Depr(5y)1159.14%
Cap/Sales(3y)516.85%
Cap/Sales(5y)328.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48.75%
EPS Next Y85.11%
EPS Next 2Y37.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.48%
Revenue growth 3Y-23.42%
Revenue growth 5Y-11.79%
Sales Q2Q%-36.6%
Revenue Next Year62.85%
Revenue Next 2Y46.86%
Revenue Next 3Y48.34%
Revenue Next 5YN/A
EBIT growth 1Y-35.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-933.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.75%
OCF growth 3YN/A
OCF growth 5YN/A

SEQUANS COMMUNICATIONS-ADR / SQNS Fundamental Analysis FAQ

What is the fundamental rating for SQNS stock?

ChartMill assigns a fundamental rating of 2 / 10 to SQNS.


What is the valuation status for SQNS stock?

ChartMill assigns a valuation rating of 1 / 10 to SEQUANS COMMUNICATIONS-ADR (SQNS). This can be considered as Overvalued.


Can you provide the profitability details for SEQUANS COMMUNICATIONS-ADR?

SEQUANS COMMUNICATIONS-ADR (SQNS) has a profitability rating of 1 / 10.


What is the expected EPS growth for SEQUANS COMMUNICATIONS-ADR (SQNS) stock?

The Earnings per Share (EPS) of SEQUANS COMMUNICATIONS-ADR (SQNS) is expected to grow by 85.11% in the next year.